Randomised clinical trial: addition of alginate ‐antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms

ConclusionsAdding Gaviscon to PPI reduced breakthrough GERD symptoms but a nearly equal response was observed for placebo. Response to intervention may vary according to whether symptoms are functional in origin.

Source: Alimentary Pharmacology and Therapeutics - May 1, 2017 Category: Drugs & Pharmacology Authors: C. Coyle, G. Crawford, J. Wilkinson, S. J. Thomas, P. Bytzer Tags: RANDOMISED CLINICAL TRIAL Source Type: research